Kelly Baekyung Choi

Kelly Baekyung Choi

Auto-generated profile, based on publicly available information

Kelly Baekyung Choi

Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Canada

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2022 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
KCKelly B. Choi
Kelly B. Choi
TDTim Du
Tim Du
ASAnada Silva
Anada Silva
GGGeorge R. Golding
George R. Golding
LPLinda Pelude
Linda Pelude
F(For The Canadian Nosocomial Infection Surveillance Program (Cnisp)
For The Canadian Nosocomial Infection Surveillance Program (Cnisp)
The coronavirus disease 2019 (COVID-19) pandemic has placed significant burden on healthcare systems. We compared Clostridioides difficile infection (CDI) epidemiology before and during the pandemic across 71 hospitals participating in the Canadian Nosocomial Infection Surveillance Program. Using an interrupted time series analysis, we showed that CDI rates significantly increased during the COVID-19 pandemic.

16 June 2022 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
KCKelly B. Choi
Kelly B. Choi
VSVivienne Steele
Vivienne Steele
JCJohn Conly
John Conly
BCBlanda Chow
Blanda Chow
JCJeannette L. Comeau
Jeannette L. Comeau
F(For The Canadian Nosocomial Infection Surveillance Program (Cnisp)
For The Canadian Nosocomial Infection Surveillance Program (Cnisp)
Cerebrospinal fluid shunt–associated surgical site infection surveillance for 3 months compared to 12 months after surgery captures 83% of cases with no significant differences in patient characteristics, surgery types, or pathogens. A shorter 3-month follow-up can reduce resource use and allow for more timely reporting of healthcare-associated infection rates for hospitals.

19 March 2026 in Canadian Journal of Public Health
Verified
Journal Article
Open access
PDF file
GGGenevieve Gravel
Genevieve Gravel
JMJoanna Merckx
Joanna Merckx
ABAmandine Bemmo
Amandine Bemmo
KCKelly Baekyung Choi
Kelly Baekyung Choi
JSJaskiran Sandhu
Jaskiran Sandhu
CKCarsten Krueger
Carsten Krueger
Objectives: The incidence of congenital syphilis (CS) in Canada increased from 2.1 to 14.5 reported confirmed cases/100,000 live births from 2017 to 2023 (from 8 to 53 cases). We aimed to document prenatal characteristics and contributing factors to CS among mothers or birthing parents (M/BP) of infants with CS in Canada. Methods: Participants of the Canadian Paediatric Surveillance Program, which includes both paediatricians and paediatric subspecialists, were invited to report on CS cases meeting the study case definition between June 2021 and May 2023. A detailed questionnaire was completed by the reporting clinician. We used descriptive statistics in the assessment of prenatal risk factors among cases, including data on healthcare access, diagnosis, and treatment as well as on socio-demographic, socio-economic and socio-behavioural determinants. Results: During the 24-month study period, 245 live-born cases of CS were reported, including 81 (33.1%) confirmed and 164 (66.9%) probable cases from seven provinces and territories. Substance use in pregnancy was reported in 65% of cases. Only half of M/BP had at least 1 prenatal care visit during their pregnancy, while only one-quarter had ≥ 1 prenatal care visit in each trimester. In a quarter of cases, no syphilis screening was performed during pregnancy. Prenatal syphilis treatment was not initiated among 20% who screened positive. Conclusion: In this country-wide assessment, we identified substantial failures in the delivery of adequate prenatal care to M/BP of live-born infants diagnosed with CS. Public health action, such as community outreach to ensure prenatal care for all pregnant people, with specific attention to the prenatal healthcare needs and engagement in the care of those who use substances, is pressing.

10 September 2025 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
ASAnada Silva
Anada Silva
JBJessica J. Bartoszko
Jessica J. Bartoszko
JCJoëlle Cayen
Joëlle Cayen
KCKelly B. Choi
Kelly B. Choi
RMRobyn Mitchell
Robyn Mitchell
NTNisha Thampi
Nisha Thampi